IGFBP5
Reactivité: Humain
WB, IF
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal conditions should be determined byt he investigator.
Restrictions
For Research Use only
Format
Lyophilized
Concentration
Lot specific
Buffer
Lyophilized from PBS, pH 7.2.
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Stock
4 °C/-20 °C
Stockage commentaire
Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.
Antigène
IGFBP5
(Insulin-Like Growth Factor Binding Protein 5 (IGFBP5))
anticorps IBP5, anticorps AI256729, anticorps AW208790, anticorps IGFBP-5, anticorps IGFBP-5P, anticorps IGF-BP5, anticorps igfbp5, anticorps ibp5, anticorps IBP-5, anticorps xIGFBP-5, anticorps IGFBP5, anticorps igfbp5b, anticorps zgc:165472, anticorps insulin like growth factor binding protein 5, anticorps insulin-like growth factor binding protein 5, anticorps insulin like growth factor binding protein 5 L homeolog, anticorps insulin-like growth factor binding protein 5b, anticorps insulin-like growth factor-binding protein 5, anticorps insulin-like growth factor binding protein 5a, anticorps IGFBP5, anticorps Igfbp5, anticorps igfbp5.L, anticorps igfbp5b, anticorps igfbp5, anticorps LOC100194500, anticorps igfbp5a
Sujet
IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP5 is a 28.6 kDa cysteine-rich secreted protein produced by vascular smooth muscle cells. It is the major IGF-binding protein present in bone tissue and helps potentiate the action of IGF-I on smooth muscle cells, fibroblasts or osteoblasts. Data shows that IGFBP-5 acts as a growth inhibitor and pro-apoptotic agent in breast cancer cells.